glp-1 receptor agonists in pediatric and adolescent obesity Oral GLP-1-Based Therapeutics the Obesity–Metabolic Syndrome–Diabetes Continuum: Translational Advances, Clinical Barriers, Emerging Strategies Pediatric Obesity: Should We Prescribe

The big question is this: Will you use tools like this to support a healthy life or depend on them without changing your habits

With the dual effect of "diabetes" and "weight loss", the development of GLP-1 long-acting receptor agonists has become a research hotspot at home and abroad

Are there safer, cheaper, natural alternatives to boost GLP-1 with diet and lifestyle

Whats the Difference Between Ozempic and Mounjaro

Two clinical trials were done on semaglutide and Alzheimers, and they did not show any benefits, Low Wang said

All the authors have contributed significantly to the manuscript, per the International Committee of Medical Journal Editors criteria of authorship